查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球胜肽合成市场（至 2029 年）包括试剂（树脂、胺基酸、染料）、设备（胜肽合成仪、层析法、冷冻干燥机）、方法（固相、溶液相、混合）、服务、应用（治疗药物）和最终用户
市场调查报告书
商品编码
1660130

全球胜肽合成市场（至 2029 年）包括试剂（树脂、胺基酸、染料）、设备（胜肽合成仪、层析法、冷冻干燥机）、方法（固相、溶液相、混合）、服务、应用（治疗药物）和最终用户

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 564 Pages | 订单完成后即时交付

价格

胜肽合成市场预计将从 2024 年的 8.1 亿美元成长到 2029 年的 14.1 亿美元以上，2024 年至 2029 年的复合年增长率为 11.7%。

肽合成市场受到多种因素的推动，包括技术进步、药物发现研究的增加以及对个人化医疗的需求不断增长。此外，癌症和糖尿病等慢性病的发生率不断上升，推动了标靶治疗对治疗胜肽的需求，进一步推动了市场的成长。

研究范围
调查年份 2022-2029
基准年 2023
预测期 2024-2029
单元 金额（美元）
部分 提供类别、产品、消耗品、设备、服务、应用程式、技术、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

“在试剂类别中，树脂和氨基酸占据了压倒性份额”

树脂是固相胜肽合成（SPPS）的基础，并作为逐步建构胜肽链的稳定平台。预装树脂和特殊连接器等树脂的进步预计将对市场产生积极影响。

“市场领先的胜肽合成服务”

基于服务，胜肽合成服务部门引领市场，因为它能够满足药物发现、治疗开发和研究应用所需的客自订和复杂胜肽日益增长的需求。此外，个人化医疗和肽基疫苗的兴起正在推动对客自订合成的需求，从而推动该领域的成长。

“从应用角度来看，治疗领域将在 2023 年引领市场”

固相胜肽合成（SPPS）和重组DNA方法等胜肽合成技术的发展使得高效生产用于疫苗开发的高纯度且经济高效的胜肽成为可能。对个人化免疫疗法的日益关注和对基于胜肽的疫苗研究的不断增加的投资进一步加强了其在市场上的主导地位。

“北美：肽合成市场的最大份额”

预计北美将在 2023 年引领市场，并有望在预测期内继续保持类似的领先地位。在主要参与者的推动下，美国正在为肽类疗法的生物医学研究和创新提供大量资金。此外，欧洲占了很大的市场份额，其中德国、英国等国贡献巨大。这项优势归功于强大的研发活动、学术和产业合作以及对个人化医疗和胜肽类药物的日益关注。

本报告调查了全球胜肽合成市场，并提供了市场概况摘要、影响市场成长的各种因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、各个细分市场、地区和主要国家的详细分析、竞争格局以及主要企业的概况。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
  • 影响我们客户业务的趋势/中断
  • 定价分析
  • 供应链分析
  • 价值链分析
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 专利分析
  • 贸易分析
  • 重要会议及活动
  • 监管状态
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 人工智慧/生成式人工智慧对胜肽合成市场的影响

第六章 胜肽合成市场细分

  • 产品
  • 服务

7. 胜肽合成产品市场按类型划分

  • 耗材
    • 试剂
    • 其他的
  • 装置
    • 胜肽合成仪
    • 层析法系统
    • 冷冻干燥机
    • 其他的

8. 胜肽合成服务市场按类型划分

  • 胜肽合成
  • 胜肽精製服务
  • 胜肽库合成
  • 胜肽分析服务

第九章 胜肽合成市场（依方法）

  • 化学方法
    • 固相胜肽合成
    • 液相胜肽合成
    • 其他的
  • 生物学方法
    • 重组DNA技术
    • 酵素合成

第 10 章 胜肽合成市场（依应用）

  • 治疗
    • 按适应症
    • 按分子
  • 诊断
  • 发现与开发

第 11 章 胜肽合成产品市场（依最终用户）

  • 製药和生物製药公司
  • 合约研究公司・合约行销公司
  • 学术研究所
  • 医疗设备公司
  • 医院和诊断中心

第 12 章 胜肽合成服务市场（依最终用户）

  • 製药和生物製药公司
  • 医疗设备公司
  • 医院和诊断中心
  • 学术研究所
  • 合约研究公司・合约行销公司

第 13 章 胜肽合成市场（按地区）

  • 北美洲
    • 宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 宏观经济展望
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东
    • 宏观经济展望
    • 海湾合作委员会国家
    • 其他的
  • 非洲
    • 宏观经济展望

第十四章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收益分析
  • 市场占有率分析
  • 企业估值与财务指标
  • 品牌/产品比较
  • 企业评估矩阵：主要企业
  • 公司估值矩阵：Start-Ups/小型企业
  • 竞争场景

第十五章 公司简介

  • 主要企业
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • AGILENT TECHNOLOGIES, INC.
    • GENSCRIPT
    • KANEKA CORPORATION
    • BACHEM
    • SYNGENE INTERNATIONAL LIMITED
    • MESA LABS, INC.
    • BIOTAGE
    • CEM CORPORATION
    • DALTON PHARMA SERVICES
    • BIO-SYNTHESIS INC.
    • CSBIO
    • PROTEOGENIX
    • INNOVAGEN AB
    • BIOSYNTH
  • 其他公司
    • AURIGENE PHARMACEUTICAL SERVICES LTD.
    • CORDENPHARMA
    • JPT PEPTIDE TECHNOLOGIES
    • PUROLITE
    • BIOMATIK
    • CPC SCIENTIFIC INC.
    • ADVANCED CHEMTECH, INC.
    • AMBIOPHARM INC.
    • LUXEMBOURG BIO TECHNOLOGIES
    • AAPPTEC
    • ANYGEN
    • CHEMPEP
    • PROTEOGENIX

第十六章 附录

Product Code: BT 6462

The global peptide synthesis market is projected to surpass USD 1.41 billion in 2029 from USD 0.81 billion in 2024, with a significant CAGR of 11.7%. The peptide synthesis market is driven by several factors such as advancements in technology, increasing research in drug discovery, and the growing demand for personalized medicine. Additionally, the rising prevalence of chronic diseases such as cancer and diabetes is fueling demand for therapeutic peptides in targeted therapies further propelling the growth of the market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsOfferings, Products, Consumables, Instruments, Services, Applications, Technique and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"Resins and Amino acids accounted for the dominant share in the reagents market"

Based on offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Resins form the foundation of solid-phase peptide synthesis (SPPS), serving as a stable platform for the stepwise construction of peptide chains. Advancements in resins such as preloaded resins and specialized linkers are likely to impact positively on the market.

"Peptide synthesis services dominated the market"

The services segment is further segmented into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. Peptide synthesis services dominated the market due to their ability to meet the increasing demand for custom and complex peptides required in drug discovery, therapeutic development, and research applications. Additionally, the rise of personalized medicine and peptide-based vaccines has increased the demand for custom synthesis driving the segmental growth.

"Therapeutics segment dominated the application segment in 2023"

Applications segment is divided into Therapeutics, Diagnostics and Research & Development. Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules). Advancements in peptide synthesis technologies, such as solid-phase peptide synthesis (SPPS) and recombinant DNA methods, has enabled the efficient production of high-purity, cost-effective peptides for vaccine development. The growing focus on personalized immunotherapies and increased investment in peptide-based vaccine research further reinforce their leading position in the market.

"North America: the largest share of the peptide synthesis market"

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the peptide synthesis market in 2023 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the strong presence of key players like Thermo Fisher Scientific and CEM Corporation, with substantial funding for biomedical research and innovation in peptide-based therapeutics. Europe holds a significant share of the market, with countries like Germany, and UK being major contributors. This dominance attributed to strong R&D activities, collaborations between academic institutions and industry, and a growing focus on personalized medicine and peptide-based drugs.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the peptide synthesis market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Tier 1- 45%, Tier 2- 35%, Tier 3- 20%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Bachem Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), GenScript (China), and CEM Corporation (US) are some of the major players operating in the peptide synthesis market.

Research Coverage:

This research report categorizes the peptide synthesis market offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Services (Peptide Library Synthesis, Peptide Synthesis, Peptide Purification Services and Peptide Analysis Services), Technique (Chemical (Solid Phase Peptide Synthesis, Solution Phase peptide synthesis and Other Chemical Methods and Biological (Recombinant DNA Technology and Enzymes), Applications (Therapeutics, Diagnostics and Research & Development), Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules), End User (Pharmaceutical and biotechnology companies, CDMOs & CROs, Academic & Research Institutes, Medical Device Companies and Hospitals and Diagnostic Centers). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the peptide synthesis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the peptide synthesis market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the peptide synthesis and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (advancements in peptide therapeutics, technological advancements,

growing use of peptides in diagnostics and research), restraints (Regulatory Hurdles, High cost of peptide synthesis and instruments), opportunities (Adoption of personalized medicine, Rise in strategic collaborations and partnerships) and Challenges (Addressing Immunogenicity, Environmental Concerns) influencing the growth of the market.

  • Product/Service Development/Innovation: Detailed insights on upcoming technologies in peptide synthesis manufacturing, research and development activities, and new product/service launches in the peptide synthesis market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peptide synthesis market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc. and Merck KGaA (Germany), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONAL SCOPE
    • 1.3.3 INCLUSIONS AND EXCLUSIONS
    • 1.3.4 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1 GLOBAL MARKET ESTIMATION
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH)
  • 2.3 GROWTH RATE PROJECTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT TYPE AND COUNTRY, 2023
  • 4.3 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029
  • 4.4 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advancements in peptide therapeutics
      • 5.2.1.2 Innovations in peptide synthesis instruments
      • 5.2.1.3 Growing use of peptides in diagnostics and research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory hurdles
      • 5.2.2.2 High cost of peptide synthesis and instruments
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of personalized medicine
      • 5.2.3.2 Strategic collaborations and partnerships
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Immunogenicity issues
      • 5.2.4.2 Environmental concerns
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS
    • 5.7.2 PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS
    • 5.7.3 PEPTIDE SYNTHESIS MARKET: END USERS
    • 5.7.4 PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Solid-phase peptide synthesis (SPPS)
      • 5.9.1.2 Liquid-phase peptide synthesis (LPPS)
      • 5.9.1.3 Enzymatic peptide synthesis
      • 5.9.1.4 Continuous-flow peptide synthesis
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Labeling and tracking technologies
      • 5.9.2.2 Purification techniques
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Cell-free protein synthesis
      • 5.9.3.2 Protein design and engineering
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE DATA FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS)
      • 5.11.1.1 Import data for HS code 902720
      • 5.11.1.2 Export data for HS CODE 902720
    • 5.11.2 TRADE DATA FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS AND SPRAY DRYERS)
      • 5.11.2.1 Import data for HS code 841993
      • 5.11.2.2 Export data for HS code 841933
  • 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 REGULATORY FRAMEWORK
      • 5.13.2.1 North America
        • 5.13.2.1.1 US
        • 5.13.2.1.2 Canada
      • 5.13.2.2 Europe
        • 5.13.2.2.1 Germany
        • 5.13.2.2.2 UK
        • 5.13.2.2.3 France
      • 5.13.2.3 Asia Pacific
        • 5.13.2.3.1 Japan
        • 5.13.2.3.2 China
      • 5.13.2.4 Latin America
        • 5.13.2.4.1 Brazil
      • 5.13.2.5 Middle East & Africa
        • 5.13.2.5.1 GCC Countries
        • 5.13.2.5.2 South Africa
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 BARGAINING POWER OF SUPPLIERS
    • 5.14.2 BARGAINING POWER OF BUYERS
    • 5.14.3 THREAT OF NEW ENTRANTS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
  • 5.16 IMPACT OF AI/GENERATIVE AI ON PEPTIDE SYNTHESIS MARKET
    • 5.16.1 INTRODUCTION
    • 5.16.2 IMPACT OF AI ON PEPTIDE SYNTHESIS ECOSYSTEM
    • 5.16.3 FUTURE OF GENERATIVE AI IN PEPTIDE SYNTHESIS ECOSYSTEM

6 PEPTIDE SYNTHESIS MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    • 6.2.1 INCREASING ADOPTION OF SOLID AND LIQUID-PHASE PEPTIDE SYNTHESIS TO STIMULATE GROWTH
  • 6.3 SERVICES
    • 6.3.1 GROWING ADVANCEMENTS IN PEPTIDE DESIGN AND SYNTHESIS OPTIMIZATION TO FUEL MARKET

7 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 CONSUMABLES
    • 7.2.1 REAGENTS
      • 7.2.1.1 Resins
        • 7.2.1.1.1 Growing demand for therapeutic peptides to boost market
      • 7.2.1.2 Amino acids
        • 7.2.1.2.1 Increasing advancements in synthetic amino acid modifications to aid growth
      • 7.2.1.3 Coupling reagents
        • 7.2.1.3.1 Rising adoption of high-throughput peptide synthesis to expedite growth
      • 7.2.1.4 Dyes & fluorescent labeling reagents
        • 7.2.1.4.1 Increasing demand for high-resolution, sensitive imaging technologies to promote growth
      • 7.2.1.5 Deprotection reagents
        • 7.2.1.5.1 Rising complexity of modified peptides and cyclic structures to facilitate growth
      • 7.2.1.6 Cleavage reagents
        • 7.2.1.6.1 Increasing use of complex peptides to sustain growth
      • 7.2.1.7 Other reagents
    • 7.2.2 OTHER CONSUMABLES
  • 7.3 INSTRUMENTS
    • 7.3.1 PEPTIDE SYNTHESIZERS
      • 7.3.1.1 Automated peptide synthesizers
        • 7.3.1.1.1 Increasing launches of automated peptide synthesizers to promote growth
      • 7.3.1.2 Manual peptide synthesizers
        • 7.3.1.2.1 Growing use of peptide synthesizers for early-stage drug discovery and research to fuel market
    • 7.3.2 CHROMATOGRAPHY SYSTEMS
      • 7.3.2.1 Increasing shift toward high-throughput and industrial-scale peptide production to amplify growth
    • 7.3.3 LYOPHILIZERS
      • 7.3.3.1 Rising influence of contract manufacturing organizations to encourage growth
    • 7.3.4 OTHER INSTRUMENTS

8 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 PEPTIDE SYNTHESIS
    • 8.2.1 RISING ADOPTION OF PERSONALIZED MEDICINES AND TARGETED THERAPIES TO INTENSIFY GROWTH
  • 8.3 PEPTIDE PURIFICATION SERVICES
    • 8.3.1 GROWING EMPHASIS ON HIGH-QUALITY PEPTIDES IN PHARMACEUTICAL DEVELOPMENT AND BIOTECH TO DRIVE MARKET
  • 8.4 PEPTIDE LIBRARY SYNTHESIS
    • 8.4.1 INCREASING FOCUS ON SYNTHETIC BIOLOGY TO AUGMENT GROWTH
  • 8.5 PEPTIDE ANALYSIS SERVICES
    • 8.5.1 INCREASING ADVANCEMENTS IN MASS SPECTROMETRY AND CHROMATOGRAPHY TO BOLSTER GROWTH

9 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE

  • 9.1 INTRODUCTION
  • 9.2 CHEMICAL METHODS
    • 9.2.1 SOLID-PHASE PEPTIDE SYNTHESIS
      • 9.2.1.1 Increasing use of peptides and peptide derivatives in modern medicines use to encourage growth
    • 9.2.2 LIQUID-PHASE PEPTIDE SYNTHESIS
      • 9.2.2.1 Growing advancements in purification technologies to boost market
    • 9.2.3 OTHER CHEMICAL METHODS
  • 9.3 BIOLOGICAL METHODS
    • 9.3.1 RECOMBINANT DNA TECHNOLOGY
      • 9.3.1.1 Increasing innovations in genetic engineering and synthetic biology to drive market
    • 9.3.2 ENZYMATIC SYNTHESIS
      • 9.3.2.1 Growing shift toward sustainable and eco-friendly manufacturing to propel market

10 PEPTIDE SYNTHESIS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 THERAPEUTIC APPLICATIONS
    • 10.2.1 THERAPEUTIC APPLICATIONS, BY INDICATION
      • 10.2.1.1 Cancer
        • 10.2.1.1.1 Rising clinical trials to contribute to growth
      • 10.2.1.2 Diabetes
        • 10.2.1.2.1 Increasing need for diabetes management to favor growth
      • 10.2.1.3 Obesity
        • 10.2.1.3.1 Increasing development of next-generation weight management therapies to foster growth
      • 10.2.1.4 Autoimmune diseases
        • 10.2.1.4.1 Growing prevalence of rheumatoid arthritis, lupus, and multiple sclerosis to fuel market
      • 10.2.1.5 Other diseases
    • 10.2.2 THERAPEUTIC APPLICATIONS, BY MOLECULE
      • 10.2.2.1 Peptide-based vaccines
        • 10.2.2.1.1 Increasing research on infectious diseases and cancer immunotherapy to augment growth
      • 10.2.2.2 Peptide-drug conjugates
        • 10.2.2.2.1 Growing focus of pharmaceutical companies on drug conjugation to drive market
      • 10.2.2.3 Peptide inhibitors
        • 10.2.2.3.1 Rising traction for precision medicine to assist growth
      • 10.2.2.4 Other molecules
  • 10.3 DIAGNOSTIC APPLICATIONS
    • 10.3.1 RISE OF PERSONALIZED MEDICINE AND POINT-OF-CARE TESTING TO ACCELERATE GROWTH
  • 10.4 DISCOVERY & DEVELOPMENT APPLICATIONS
    • 10.4.1 GROWING ADVANCEMENTS IN COMBINATORIAL CHEMISTRY AND HIGH-THROUGHPUT PEPTIDE LIBRARIES TO DRIVE MARKET

11 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 11.2.1 INCREASING RESEARCH ON GENOMICS AND MOLECULAR BIOLOGY TO EXPEDITE GROWTH
  • 11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
    • 11.3.1 SHIFT TOWARD CUSTOM AND MODIFIED PEPTIDES TO DRIVE MARKET
  • 11.4 ACADEMIC & RESEARCH INSTITUTES
    • 11.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO SUPPORT GROWTH
  • 11.5 MEDICAL DEVICE COMPANIES
    • 11.5.1 BOOMING PEPTIDE-BASED DRUG DELIVERIES TO PROMOTE GROWTH
  • 11.6 HOSPITALS & DIAGNOSTIC CENTERS
    • 11.6.1 RISING DEMAND FOR PEPTIDE-BASED DIAGNOSTICS TO FAVOR GROWTH

12 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER

  • 12.1 INTRODUCTION
  • 12.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 12.2.1 INCREASING FOCUS ON PEPTIDE-BASED THERAPEUTICS IN ONCOLOGY AND METABOLIC DISORDERS TO INTENSIFY GROWTH
  • 12.3 MEDICAL DEVICE COMPANIES
    • 12.3.1 NEED TO DETECT INFECTIOUS DISEASES, CANCER, AND METABOLIC DISORDERS TO AID GROWTH
  • 12.4 HOSPITALS & DIAGNOSTIC CENTERS
    • 12.4.1 RISING USE OF PEPTIDE BIOMARKERS TO SUPPORT GROWTH
  • 12.5 ACADEMIC & RESEARCH INSTITUTES
    • 12.5.1 GROWING FOCUS ON DRUG DESIGN, VACCINE DEVELOPMENT, AND CANCER RESEARCH TO BOOST MARKET
  • 12.6 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
    • 12.6.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO FACILITATE GROWTH

13 PEPTIDE SYNTHESIS MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 13.2.2 US
      • 13.2.2.1 Well-developed healthcare and research infrastructure to aid growth
    • 13.2.3 CANADA
      • 13.2.3.1 Increasing government funding for advanced drugs to amplify growth
  • 13.3 EUROPE
    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 13.3.2 GERMANY
      • 13.3.2.1 Germany to hold largest market share in Europe
    • 13.3.3 UK
      • 13.3.3.1 Increasing peptide synthesis research to contribute to growth
    • 13.3.4 FRANCE
      • 13.3.4.1 Favorable government initiatives to augment growth
    • 13.3.5 ITALY
      • 13.3.5.1 Growing public and private sector investments to propel market
    • 13.3.6 SPAIN
      • 13.3.6.1 Rising focus on advanced therapies to expedite growth
    • 13.3.7 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 13.4.2 CHINA
      • 13.4.2.1 Expanding biopharma sector to advance growth
    • 13.4.3 JAPAN
      • 13.4.3.1 Growing geriatric population to fuel market
    • 13.4.4 INDIA
      • 13.4.4.1 Increasing investments and developments in biotechnology to favor growth
    • 13.4.5 SOUTH KOREA
      • 13.4.5.1 Booming biotechnology sector to amplify growth
    • 13.4.6 AUSTRALIA
      • 13.4.6.1 Increasing government funding and initiatives to augment growth
    • 13.4.7 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 13.5.2 BRAZIL
      • 13.5.2.1 Growing interest in peptide-based drugs to fuel market
    • 13.5.3 MEXICO
      • 13.5.3.1 Increasing initiatives for stem cell research and regenerative medicine projects to foster growth
    • 13.5.4 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST
    • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 13.6.2 GCC COUNTRIES
      • 13.6.2.1 Saudi Arabia
        • 13.6.2.1.1 Increasing government-backed investments for infrastructure to aid growth
      • 13.6.2.2 UAE
        • 13.6.2.2.1 High prevalence of diabetes and cardiovascular diseases to augment growth
      • 13.6.2.3 Rest of GCC Countries
    • 13.6.3 REST OF MIDDLE EAST
  • 13.7 AFRICA
    • 13.7.1 INCREASING INVESTMENTS IN PHARMACEUTICAL INFRASTRUCTURE AND LIFE SCIENCE INNOVATIONS TO BOOST MARKET
    • 13.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET
  • 14.3 REVENUE ANALYSIS, 2019-2023
  • 14.4 MARKET SHARE ANALYSIS, 2023
  • 14.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 14.5.1 COMPANY VALUATION
    • 14.5.2 FINANCIAL METRICS
  • 14.6 BRAND/PRODUCT COMPARISON
  • 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 14.7.1 STARS
    • 14.7.2 EMERGING LEADERS
    • 14.7.3 PERVASIVE PLAYERS
    • 14.7.4 PARTICIPANTS
    • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 14.7.5.1 Company footprint
      • 14.7.5.2 Region footprint
      • 14.7.5.3 Offering footprint
      • 14.7.5.4 Technique footprint
      • 14.7.5.5 Application footprint
  • 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 14.8.1 PROGRESSIVE COMPANIES
    • 14.8.2 RESPONSIVE COMPANIES
    • 14.8.3 DYNAMIC COMPANIES
    • 14.8.4 STARTING BLOCKS
    • 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 14.8.5.1 Detailed list of key startups/SMEs
      • 14.8.5.2 Competitive benchmarking of startups/SMEs
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT LAUNCHES
    • 14.9.2 DEALS
    • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 THERMO FISHER SCIENTIFIC INC.
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products/Services offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Key strengths
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses and competitive threats
    • 15.1.2 MERCK KGAA
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products/Services offered
      • 15.1.2.3 MnM view
        • 15.1.2.3.1 Key strengths
        • 15.1.2.3.2 Strategic choices
        • 15.1.2.3.3 Weaknesses and competitive threats
    • 15.1.3 AGILENT TECHNOLOGIES, INC.
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products/Services offered
      • 15.1.3.3 MnM view
        • 15.1.3.3.1 Key strengths
        • 15.1.3.3.2 Strategic choices
        • 15.1.3.3.3 Weaknesses and competitive threats
    • 15.1.4 GENSCRIPT
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products/Services offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Expansions
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Key strengths
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses and competitive threats
    • 15.1.5 KANEKA CORPORATION
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products/Services offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Expansions
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Key strengths
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses and competitive threats
    • 15.1.6 BACHEM
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products/Services offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Deals
    • 15.1.7 SYNGENE INTERNATIONAL LIMITED
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products/Services offered
    • 15.1.8 MESA LABS, INC.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products/Services offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches
        • 15.1.8.3.2 Deals
    • 15.1.9 BIOTAGE
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products/Services offered
    • 15.1.10 CEM CORPORATION
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products/Services offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches
        • 15.1.10.3.2 Deals
    • 15.1.11 DALTON PHARMA SERVICES
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products/Services offered
    • 15.1.12 BIO-SYNTHESIS INC.
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products/Services offered
    • 15.1.13 CSBIO
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products/Services offered
    • 15.1.14 PROTEOGENIX
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products/Services offered
    • 15.1.15 INNOVAGEN AB
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products/Services offered
    • 15.1.16 BIOSYNTH
      • 15.1.16.1 Business overview
      • 15.1.16.2 Products/Services offered
        • 15.1.16.2.1 Deals
  • 15.2 OTHER PLAYERS
    • 15.2.1 AURIGENE PHARMACEUTICAL SERVICES LTD.
    • 15.2.2 CORDENPHARMA
    • 15.2.3 JPT PEPTIDE TECHNOLOGIES
    • 15.2.4 PUROLITE
    • 15.2.5 BIOMATIK
    • 15.2.6 CPC SCIENTIFIC INC.
    • 15.2.7 ADVANCED CHEMTECH, INC.
    • 15.2.8 AMBIOPHARM INC.
    • 15.2.9 LUXEMBOURG BIO TECHNOLOGIES
    • 15.2.10 AAPPTEC
    • 15.2.11 ANYGEN
    • 15.2.12 CHEMPEP
    • 15.2.13 PROTEOGENIX

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 PEPTIDE SYNTHESIS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 PEPTIDE SYNTHESIS MARKET: RISK ANALYSIS
  • TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2022-2024
  • TABLE 6 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2022-2024
  • TABLE 7 PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS
  • TABLE 8 PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS
  • TABLE 9 PEPTIDE SYNTHESIS MARKET: END USERS
  • TABLE 10 PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES
  • TABLE 11 PEPTIDE SYNTHESIS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024
  • TABLE 12 IMPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019-2023 (USD)
  • TABLE 13 EXPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019-2023 (USD)
  • TABLE 14 IMPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022-2023 (USD)
  • TABLE 15 EXPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022-2023 (USD)
  • TABLE 16 PEPTIDE SYNTHESIS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 PEPTIDE SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS
  • TABLE 24 KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER
  • TABLE 25 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 26 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 41 PEPTIDE CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 42 PEPTIDE CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 EUROPE: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: PEPTIDE CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 RESINS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: RESINS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: RESINS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: RESINS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: RESINS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 MIDDLE EAST: RESINS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: RESINS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 AMINO ACIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 EUROPE: AMINO ACIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: AMINO ACIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: AMINO ACIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: AMINO ACIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 COUPLING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: COUPLING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: COUPLING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST: COUPLING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 GCC COUNTRIES: COUPLING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 EUROPE: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 LATIN AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 MIDDLE EAST: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 GCC COUNTRIES: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 DEPROTECTION REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 MIDDLE EAST: DEPROTECTION REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 91 GCC COUNTRIES: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 CLEAVAGE REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 MIDDLE EAST: CLEAVAGE REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 GCC COUNTRIES: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 112 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 EUROPE: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 LYOPHILIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 EUROPE: LYOPHILIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: LYOPHILIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST: LYOPHILIZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: LYOPHILIZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 158 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 EUROPE: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 163 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 173 NORTH AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 EUROPE: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 LATIN AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 MIDDLE EAST: PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 178 GCC COUNTRIES: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 EUROPE: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 LATIN AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 MIDDLE EAST: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 185 GCC COUNTRIES: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 187 NORTH AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 EUROPE: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 LATIN AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 191 MIDDLE EAST: PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 192 GCC COUNTRIES: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 194 PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 EUROPE: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 LATIN AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 225 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 232 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 233 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 234 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 235 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 237 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 239 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 240 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 243 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 246 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 247 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 248 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 254 PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 256 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 261 PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 263 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 265 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 268 PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 270 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 275 PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 276 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 277 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 280 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 282 PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 283 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 284 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 287 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 288 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 289 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 290 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 292 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 295 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 297 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 299 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 302 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 304 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 306 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 311 PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 312 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 313 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 315 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 316 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 317 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 318 PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 319 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 320 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 322 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 323 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 324 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 325 PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 326 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 327 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 329 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 330 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 331 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 332 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 333 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 334 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 335 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 338 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 339 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 340 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 341 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 342 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 344 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 345 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 346 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 347 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 348 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 349 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 351 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 352 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 354 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 355 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 356 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 357 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 358 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 359 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 360 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 361 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 362 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 363 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 364 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 365 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 366 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 368 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 369 PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 370 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 371 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 372 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 373 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 374 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 375 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 376 PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 377 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 378 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 380 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 381 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 382 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 383 PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 384 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 385 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 387 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 388 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 389 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 390 PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 391 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 392 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 393 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 395 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 396 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 397 PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 398 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 399 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 400 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 401 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 402 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 403 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 404 PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 405 KEY MACROECONOMIC INDICATORS FOR NORTH AMERICA
  • TABLE 406 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 407 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 408 NORTH AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 409 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 410 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 411 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 412 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 413 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 414 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 415 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 416 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 417 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 418 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 419 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 420 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 421 US: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 422 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 423 US: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 424 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 425 US: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 426 US: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 427 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 428 US: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 429 US: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 430 US: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 431 US: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 432 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 433 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 434 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 435 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 436 CANADA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 437 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 438 CANADA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 439 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 440 CANADA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 441 CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 442 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 443 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 444 CANADA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 445 CANADA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 446 CANADA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 447 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 448 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 449 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 450 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 451 KEY MACROECONOMIC INDICATORS FOR EUROPE
  • TABLE 452 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 453 EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 454 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 455 EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 456 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 457 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 458 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 459 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 460 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 461 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 462 EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 463 EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 464 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 465 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 466 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 467 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 468 GERMANY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 469 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 470 GERMANY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 471 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 472 GERMANY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 473 GERMANY: PEPTIDE SYNTHESIS SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 474 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 475 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 476 GERMANY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 477 GERMANY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 478 GERMANY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 479 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 480 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 481 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 482 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 483 UK: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 484 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 485 UK: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 486 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 487 UK: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 488 UK: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 489 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 490 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 491 UK: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 492 UK: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 493 UK: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 494 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 495 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 496 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 497 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 498 FRANCE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 499 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 500 FRANCE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 501 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 502 FRANCE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 503 FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 504 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 505 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 506 FRANCE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 507 FRANCE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 508 FRANCE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 509 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 510 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 511 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 512 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 513 ITALY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 514 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 515 ITALY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 516 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 517 ITALY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 518 ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 519 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 520 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 521 ITALY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 522 ITALY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 523 ITALY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 524 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 525 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 526 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 527 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 528 SPAIN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 529 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 530 SPAIN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 531 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 532 SPAIN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 533 SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 534 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 535 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 536 SPAIN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 537 SPAIN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 538 SPAIN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 539 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 540 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 541 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 542 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 543 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 544 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 545 REST OF EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 546 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 547 REST OF EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 548 REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 549 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 550 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 551 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 552 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 553 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 554 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 555 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 556 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 557 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 558 KEY MACROECONOMIC INDICATORS FOR ASIA PACIFIC
  • TABLE 559 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 560 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 561 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 562 ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 563 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 564 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 565 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 566 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 567 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 568 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 569 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 570 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 571 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 572 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 573 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 574 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 575 CHINA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 576 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 577 CHINA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 578 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 579 CHINA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 580 CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 581 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 582 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 583 CHINA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 584 CHINA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 585 CHINA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 586 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 587 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 588 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 589 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 590 JAPAN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 591 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 592 JAPAN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 593 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 594 JAPAN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 595 JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 596 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 597 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 598 JAPAN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 599 JAPAN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 600 JAPAN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 601 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 602 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 603 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 604 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 605 INDIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 606 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 607 INDIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 608 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 609 INDIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 610 INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 611 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 612 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 613 INDIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 614 INDIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 615 INDIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 616 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 617 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 618 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 619 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 620 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 621 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 622 SOUTH KOREA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 623 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 624 SOUTH KOREA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 625 SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 626 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 627 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 628 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 629 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 630 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 631 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 632 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 633 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 634 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 635 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 636 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 637 AUSTRALIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 638 AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 639 AUSTRALIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 640 AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 641 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 642 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 643 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 644 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 645 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 646 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 647 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 648 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 649 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 650 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 651 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 652 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 653 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 654 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 655 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 656 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 657 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 658 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 659 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 660 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 661 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 662 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 663 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 664 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 665 KEY MACROECONOMIC INDICATORS FOR LATIN AMERICA
  • TABLE 666 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 667 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 668 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 669 LATIN AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 670 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 671 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 672 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 673 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 674 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 675 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 676 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 677 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 678 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 679 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 680 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 681 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 682 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 683 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 684 BRAZIL: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 685 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 686 BRAZIL: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 687 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 688 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 689 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 690 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 691 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 692 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 693 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 694 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 695 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 696 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 697 MEXICO: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 698 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 699 MEXICO: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 700 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 701 MEXICO: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 702 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 703 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 704 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 705 MEXICO: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 706 MEXICO: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 707 MEXICO: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 708 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 709 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 710 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 711 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 712 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 713 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 714 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 715 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 716 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 717 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 718 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 719 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 720 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 721 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 722 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 723 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 724 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 725 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 726 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 727 KEY MACROECONOMIC INDICATORS FOR MIDDLE EAST
  • TABLE 728 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 729 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 730 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 731 MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 732 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 733 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 734 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 735 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 736 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 737 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 738 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 739 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 740 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 741 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 742 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 743 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 744 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 745 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 746 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 747 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 748 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 749 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 750 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 751 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 752 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 753 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 754 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 755 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 756 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 757 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 758 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 759 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 760 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 761 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 762 SAUDI ARABIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 763 SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 764 SAUDI ARABIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 765 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 766 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 767 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 768 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHOD, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 769 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 770 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 771 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 772 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 773 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 774 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 775 UAE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 776 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 777 UAE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 778 UAE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 779 UAE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 780 UAE: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 781 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 782 UAE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 783 UAE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 784 UAE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 785 UAE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 786 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 787 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 788 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 789 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 790 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 791 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 792 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 793 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 794 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 795 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 796 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 797 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 798 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 799 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 800 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 801 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 802 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 803 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 804 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 805 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 806 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 807 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 808 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 809 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 810 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 811 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 812 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 813 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 814 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 815 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 816 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 817 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 818 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 819 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 820 KEY MACROECONOMIC INDICATORS FOR AFRICA
  • TABLE 821 AFRICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 822 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 823 AFRICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 824 AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 825 AFRICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 826 AFRICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 827 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 828 AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • TABLE 829 AFRICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 830 AFRICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 831 AFRICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 832 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022-2029 (USD MILLION)
  • TABLE 833 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022-2029 (USD MILLION)
  • TABLE 834 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 835 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 836 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021-2025
  • TABLE 837 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
  • TABLE 838 PEPTIDE SYNTHESIS MARKET: REGION FOOTPRINT
  • TABLE 839 PEPTIDE SYNTHESIS MARKET: OFFERING FOOTPRINT
  • TABLE 840 PEPTIDE SYNTHESIS MARKET: TECHNIQUE FOOTPRINT
  • TABLE 841 PEPTIDE SYNTHESIS MARKET: APPLICATION FOOTPRINT
  • TABLE 842 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 843 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 844 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 845 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 846 PEPTIDE SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 847 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 848 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 849 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 850 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 851 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 852 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 853 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 854 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 855 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 856 GENSCRIPT: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 857 KANEKA CORPORATION: COMPANY OVERVIEW
  • TABLE 858 KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 859 KANEKA CORPORATION: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 860 BACHEM: COMPANY OVERVIEW
  • TABLE 861 BACHEM: PRODUCTS/SERVICES OFFERED
  • TABLE 862 BACHEM: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 863 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
  • TABLE 864 SYNGENE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED
  • TABLE 865 MESA LABS, INC.: COMPANY OVERVIEW
  • TABLE 866 MESA LABS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 867 MESA LABS, INC.: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 868 MESA LABS, INC.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 869 BIOTAGE: COMPANY OVERVIEW
  • TABLE 870 BIOTAGE: PRODUCTS/SERVICES OFFERED
  • TABLE 871 CEM CORPORATION: COMPANY OVERVIEW
  • TABLE 872 CEM CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 873 CEM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
  • TABLE 874 CEM CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 875 DALTON PHARMA SERVICES: COMPANY OVERVIEW
  • TABLE 876 DALTON PHARMA SERVICES: PRODUCTS/SERVICES OFFERED
  • TABLE 877 BIO-SYNTHESIS INC.: COMPANY OVERVIEW
  • TABLE 878 BIO-SYNTHESIS INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 879 CSBIO: COMPANY OVERVIEW
  • TABLE 880 CSBIO: PRODUCTS/SERVICES OFFERED
  • TABLE 881 PROTEOGENIX: COMPANY OVERVIEW
  • TABLE 882 PROTEOGENIX: PRODUCTS/SERVICES OFFERED
  • TABLE 883 INNOVAGEN AB: COMPANY OVERVIEW
  • TABLE 884 INNOVAGEN AB: PRODUCTS/SERVICES OFFERED
  • TABLE 885 BIOSYNTH: COMPANY OVERVIEW
  • TABLE 886 BIOSYNTH: PRODUCTS/SERVICES OFFERED
  • TABLE 887 BIOSYNTH: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 888 AURIGENE PHARMACEUTICAL SERVICES LTD.: COMPANY OVERVIEW
  • TABLE 889 CORDENPHARMA: COMPANY OVERVIEW
  • TABLE 890 JPT PEPTIDE TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 891 PUROLITE: COMPANY OVERVIEW
  • TABLE 892 BIOMATIK: COMPANY OVERVIEW
  • TABLE 893 CPC SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 894 ADVANCED CHEMTECH, INC.: COMPANY OVERVIEW
  • TABLE 895 AMBIOPHARM INC.: COMPANY OVERVIEW
  • TABLE 896 LUXEMBOURG BIO TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 897 AAPPTEC: COMPANY OVERVIEW
  • TABLE 898 ANYGEN: COMPANY OVERVIEW
  • TABLE 899 CHEMPEP: COMPANY OVERVIEW
  • TABLE 900 PROTEOGENIX: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PEPTIDE SYNTHESIS MARKET SEGMENTATION
  • FIGURE 2 PEPTIDE SYNTHESIS MARKET: RESEARCH DESIGN
  • FIGURE 3 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF PEPTIDE SYNTHESIS MARKET, 2024-2029
  • FIGURE 19 EXPANDING APPLICATIONS OF PEPTIDES IN DIAGNOSTICS, THERAPEUTICS, AND VACCINES TO DRIVE MARKET
  • FIGURE 20 CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2023
  • FIGURE 21 PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 22 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 PEPTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 25 AVERAGE SELLING PRICE OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2024
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY TYPE, 2022-2024
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2024
  • FIGURE 28 PEPTIDE SYNTHESIS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 PEPTIDE SYNTHESIS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 PEPTIDE SYNTHESIS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 PEPTIDE SYNTHESIS MARKET: PATENT ANALYSIS, 2014-2024
  • FIGURE 32 PEPTIDE SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS
  • FIGURE 34 KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER
  • FIGURE 35 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2019-2023
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2023
  • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025
  • FIGURE 41 PEPTIDE SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 42 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PEPTIDE SYNTHESIS MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 49 KANEKA CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BACHEM: COMPANY SNAPSHOT (2023)
  • FIGURE 51 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 52 MESA LABS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIOTAGE: COMPANY SNAPSHOT (2023)